CLEVELAND, OHIO, OH, UNITED STATES, February 24, 2026 /EINPresswire.com/ — The Bommer Group, a life sciences-focused executive search firm, today announced the launch of its Computational Life Sciences Practice, a dedicated capability focused on recruiting executive and senior technical leaders at the intersection of biology, chemistry, artificial intelligence, and data science.
As AI-enabled drug discovery and computational platforms become central to therapeutic innovation, the demand for leaders who can integrate computational strategy with experimental biology and chemistry continues to accelerate. The Bommer Group’s new practice is designed to meet this growing market need.
“Drug discovery is evolving rapidly,” said Ashleigh Bommer, Founder of The Bommer Group. “Organizations are no longer experimenting with AI as a peripheral capability; it is becoming core to how discovery is conducted. Our Computational Practice reflects the industry’s shift toward integrated scientific and technological leadership.”
Meeting a Critical Talent Gap in Life Sciences
The life sciences sector is experiencing a widening talent gap for leaders who can:
Build and scale AI-enabled discovery platforms
Bridge computational and wet lab teams
Translate technical capabilities into strategic partnerships
Inform validation strategy and pipeline direction
Lead cross-functional, data-driven organizations
The Bommer Group’s Computational Practice will focus on executive and senior-level searches, including:
Chief Technology Officer (Computational / AI)
Head of Computational Biology
VP, AI/ML
Head of Data Science
Platform Strategy Leaders
AI-enabled Business Development Executives
The practice will support venture-backed biotech companies, platform-driven therapeutics organizations, and established pharmaceutical companies investing in advanced computational infrastructure.
A Strategic Approach to Computational Hiring
Unlike traditional technology recruiting, computational life sciences leadership requires a nuanced understanding of scientific translation, drug discovery workflows, and partnership dynamics.
The Bommer Group brings deep experience across platform biotech, translational science, and executive business development leadership, enabling the firm to assess not only technical depth, but also scientific credibility, cross-functional integration capability, and enterprise impact.
“Our role is not simply to identify technical talent,” Bommer added. “It is to help our clients build leadership teams capable of transforming computational innovation into validated science and strategic growth.”
About The Bommer Group
The Bommer Group is a life sciences executive search firm partnering with venture-backed and growth-stage companies to build transformative leadership teams. The firm specializes in recruiting executives across biotechnology, platform innovation, and strategic growth functions.
With the launch of its Computational Life Sciences Practice, The Bommer Group continues to expand its capabilities in response to the evolving needs of the biopharmaceutical ecosystem.
Media Contact:
Ashleigh Bommer
Founder, The Bommer Group
info@thebommergroup.com
(216) 343-0168
www.thebommergroup.com
+1 216-859-3503
Ashleigh Bommer
The Bommer Group
email us here
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
